Anti-tumour and immuno-modulation effects of triptolide-loaded polymeric micelles

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 70, Issue 3, 2008, Pages 741-748

  Xu, Lingyun ^a   Chen, Huabing ^a   Xu, Huibi ^a   Yang, Xiangliang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

A2780 cells; Anti tumour; Immuno modulation; Polymeric micelles; Sarcoma 180 bearing mice; Triptolide

Indexed keywords

COPOLYMER; DRUG CARRIER; INTERLEUKIN 2; METHOXYPOLYETHYLENEGLYCOL; POLYMER; TRIPTOLIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LYMPHOCYTE PROLIFERATION; MALE; MICELLE; MOUSE; NANOENCAPSULATION; NONHUMAN; SARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG CARRIERS; DRUG COMPOUNDING; DRUG STABILITY; EPOXY COMPOUNDS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; MALE; MICE; MICELLES; PARTICLE SIZE; PHENANTHRENES; POLYESTERS; POLYETHYLENE GLYCOLS; SARCOMA 180; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS;

EID: 54949151426     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2008.07.017     Document Type: Article

References (33)

1. Brinker A.M., Ma J., Lipsky P.E., and Raskin I. Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae). Phytochemistry 68 (2007) 732-766
2. Tengchaisri T., Chawengkirttikul R., Rachaphaew N., Reutrakul V., Sangsuwan R., and Sirisinha S. Anti-tumor activity of triptolide against cholangiocarcinoma growth in vitro and in hamsters. Cancer Lett. 133 (1998) 169-175
3. Chan E.W., Cheng S.C., Sin F.W., and Xie Y. Triptolide induced cytotoxic effects on human promyelocytic leukemia, T cell lymphoma and human hepatocellular carcinoma cell lines. Toxicol. Lett. 122 (2001) 81-87
4. Kiviharju T.M., Lecane P.S., Sellers R.G., and Peehl D.M. Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin. Cancer Res. 8 (2002) 2666-2674
5. Yang S.M., Chen J.G., Guo Z., Xu X.M., Wang L.P., Pei X.F., Yang J., Underhill C.B., and Zhang L.R. Triptolide inhibits the growth and metastasis of solid tumors. Mol. Cancer Ther. 2 (2003) 65-72
6. Zhou G.X., Ding X.L., Huang J.F., Zhang H., and Wu S.B. Suppression of 5-lipoxygenase gene is involved in triptolide-induced apoptosis in pancreatic tumor cell lines. Biochem. Biophys. Acta 1770 (2007) 1021-1027
7. Lu H., Hachida M., Enosawa S., Li X.K., Suzuki S., and Koyanagi H. Immunosuppressive effect of triptolide in vitro. Transplant. Proc. 31 (1999) 2056-2057
8. Gross S., and Walden P. Immunosuppressive mechanisms in human tumors: why we still cannot cure cancer. Immunol. Lett. 116 (2008) 7-14
9. Gaumann A., Schlitt H.J., and Geissler E.K. Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin. Transpl. Int. 21 3 (2008) 207-217
10. Xiong F.L., Chen H.B., Chang X.L., Yang Y.J., Xu H.B., and Yang X.L. Research progress of triptolide-loaded nanoparticles delivery systems. Conf. Proc. IEEE Eng. Med. Biol. Soc. 5 (2005) 4966-4969
11. Zheng Q., Gong T., Sun X., and Zhang Z.R. Synthesis, characterization and in vitro evaluation of triptolide-lysozyme conjugate for renal targeting delivery of triptolide. Arch. Pharm. Res. 29 (2006) 1164-1170
12. Nishiyama N., and Kataoka K. Current state, achievements and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol. Ther. 112 (2006) 630-648
13. Kawano K., Watanab M., Yamamoto T., Yokoyama M., Opanasopit P., Okano T., and Maitani Y. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J. Control. Release 112 (2006) 329-332
14. Yasugi K., Nagasaki Y., Kato M., and Kataoka K. Preparation and characterization of polymer micelles from poly (ethylene glycol)-poly (d,l-lactide) block copolymers as potential drug carrier. J. Control. Release 62 (1999) 89-100
15. Yamamoto Y., Yasugi K., Harada A., Nagasaki Y., and Kataoka K. Temperature-related change in the properties relevant to drug delivery of poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles in aqueous milieu. J. Control. Release 82 (2002) 359-371
16. Xu X.Y., Li L., Zhou J.P., Lu S.Y., Yang J., Yin X.J., and Ren J.S. Preparation and characterization of N-succinyl-N′-octyl chitosan micelles as doxorubicin carriers for effective anti-tumor activity. Colloids Surf. B Biointerfaces 55 (2007) 222-228
17. Aliabadi H.M., Elhasi S., Mahmud A., Gulamhusein R., Mahdipoor P., and Lavasanifar A. Encapsulation of hydrophobic drugs in polymeric micelles through co-solvent evaporation: the effect of solvent composition on micellar properties and drug loading. Int. J. Pharm. 329 (2007) 158-165
18. Zhang L.Y., Yang M., Wang Q., Li Y., Guo R., Jiang X.Q., Yang C.Z., and Liu B.R. 10-Hydroxycamptothecin loaded nanoparticles: preparation and antitumor activity in mice. J. Control. Release 119 (2007) 153-162
19. Yuan H.M., Song J.M., Li X.G., Li N., and Dai J.C. Immunomodulation and antitumor activity of k-carrageenan oligosaccharides. Cancer Lett. 243 (2006) 228-234
20. Egan R.W., Jones M.A., and Lehninger A.L. Hydrophile-lipophile balance and critical micelle concentration as key factors influencing surfactant disruption of mitochondrial membranes. J. Biol. Chem. 251 (1976) 4442-4447
21. Schott H. Solubility parameter and hydrophilic-lipophilic balance of nonionic surfactants. J. Pharm. Sci. 73 (1984) 790-792
22. Kim S.C., Kim D.W., Shim Y.H., Bang J.S., Oh H.S., Kim S.W., and Seoa M.H. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J. Control. Release 72 (2001) 191-202
23. Liu M.X., Dong J., Yang Y.J., Yang X.L., and Xu H.B. Characterization and release of triptolide-loaded poly (d,l-lactic acid) nanoparticles. Eur. Polym. J. 41 (2005) 375-382
24. Miyata Y., Sato T., and Ito A. Triptolide, a diterpenoid triepoxide, induces anti-tumor proliferation via activation of c-Jun NH2-terminal kinase 1 by decreasing phosphatidylinositol 3-kinase activity in human tumor cells. Biochem. Biophys. Res. Commun. 336 (2005) 1081-1086
25. Jiang X.H., Wong B.C., Lin M.C., Kung H.F., Zhu G.H., and Jiang S.H. Functional p53 is required for triptolide induced apoptosis and AP-1 and nuclear factor-kB activation in gastric cancer cells. Oncogene 20 (2001) 8009-8018
26. Fang C., Shi B., Pei Y.Y., Hong M.H., Wu J., and Chen H.Z. In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur. J. Pharm. Sci. 27 (2006) 27-36
27. Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J. Drug Target. 15 (2007) 457-464
28. He T., Tang C., Xu S., Moyana T., and Xiang J. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity. Cell. Mol. Immunol. 4 (2007) 105-111
29. Qiu D.M., and Kao P.N. Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook f. Drugs R D 4 (2003) 1-18
30. Zhou J., Xiao C., Zhao L.H., Jia H.W., Zhao N., Lu C., Yang D.J., Tang J.C.-O., Chan A.S.C., and Lu A.P. The effect of triptolide on CD4+ and CD8+ cells in Peyer's patch of SD rats with collagen induced arthritis. Int. Immunopharmacol. 6 (2006) 198-203
31. Oberyszyn T.M. Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D. Cancer Lett. 261 (2008) 127-136
32. Miura H., Onishi H., Sasatsu M., and Machida Y. Antitumor characteristics of methoxypolyethylene glycol-poly(d,l-lactic acid) nanoparticles containing camptothecin. J. Control. Release 97 (2004) 101-113
33. Molavi O., Ma Z., Mahmud A., Alshamsan A., Samuel J., Lai R., Kwon G.S., and Lavasanifar A. Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int. J. Pharm. 347 (2008) 118-127